A randomized, double‐blind, placebo‐controlled phase 2 study of SHR‐1707, an anti‐amyloid‐β antibody, in patients with mild cognitive impairment and mild Alzheimer's disease

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70859_100046
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A randomized, double‐blind, placebo‐controlled phase 2 study of SHR‐1707, an anti‐amyloid‐β antibody, in patients with mild cognitive impairment and mild Alzheimer's disease

C. Xie, K Wang, Junpeng Zhuang, X. Wang et al.
Alzheimer s & Dementia
Alzheimer's disease research and treatments
article

A randomized, double‐blind, placebo‐controlled phase 2 study of SHR‐1707, an anti‐amyloid‐β antibody, in patients with mild cognitive impairment and mild Alzheimer's disease

C. Xie, K Wang, Junpeng Zhuang, X. Wang, Sheng Jun Feng, Z. Y. Cheng, Yuqi Wang, Ye Xu, Gang Cheng, Hongyan Qiu, Qidong Chen, Jiong Shi, Shenyu Zhao, Qiong Wang, Guoping Peng, Yi Li, Xinyi Lv, Yun Xu, Jiehao Zhao, Jin‐Tai Yu, Qing'e Zhang, Yong Ji, Li Yang, Xia Li
article en

Abstract

No abstract available for this paper.
Alzheimer s & DementiaVol. 21(S5)
University of Science and Technology of China (CN), Shanghai Jiao Tong University (CN), Anhui Medical University (CN), Fudan University (CN), Tianjin Medical University General Hospital (CN), Shanghai Mental Health Center (CN), Beijing Tian Tan Hospital (CN), Tianjin Huanhu Hospital (CN), Zhongda Hospital Southeast University (CN), Nanjing Drum Tower Hospital (CN), Beijing Anding Hospital (CN), First Affiliated Hospital of Anhui Medical University (CN), Jiangsu Hengrui Medicine (China) (CN), Guangdong Provincial People's Hospital (CN), First Affiliated Hospital of Zhengzhou University (CN), Huashan Hospital (CN), Qilu Hospital of Shandong University (CN), Hefei First People's Hospital (CN), First Affiliated Hospital Zhejiang University (CN)
Openalex Percentile: Top 33%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A randomized, double‐blind, placebo‐controlled phase 2 study of SHR‐1707, an anti‐amyloid‐β antibody, in patients with mild cognitive impairment and mild Alzheimer's disease — C. Xie, K Wang, et al. · Alzheimer s & Dementia (2025) | TGRS Research Map | TGRS